Perspective
Alzheimer’s Drugs Deserve a Second Opinion
July 13, 2026
Featured Experts: Paul Aisen, MD, Joseph Grogan, JD
Research
All Research Featured Research
News
Medicare’s $35 Insulin Cap Lowered Beneficiary Costs, Increased Use for Some
June 8, 2026
Featured Experts: Rebecca Myerson, PhD, MPH, Dana Goldman, PhD
Comment Letter
Comments on Proposed GLOBE and GUARD Models
February 27, 2026
Featured Experts: Alice Chen, PhD, Darius Lakdawalla, PhD, Barry Liden, JD
News
PBM Markets for Medicare Part D or Medicaid Are Highly Concentrated in Nearly Every State
February 6, 2026
Featured Experts: Dima M. Qato, PharmD, MPH, PhD
Perspective
Assessing the Case Against Direct-to-Consumer Drug Advertisements
November 14, 2025
Featured Experts: Neeraj Sood, PhD
Perspective
Stop Overloading Older Adults With Medicare Plan Choices
October 21, 2025
Featured Experts: Wändi Bruine de Bruin, MSc, PhD, Jonathan Blum
Issue Brief
Operational and Policy Considerations in the Effectuation of Medicare’s Maximum Fair Drug Prices for Part D
October 16, 2025
Featured Experts: John M. Coster, PhD, RPh
News
Narrower Coverage of MS Drugs Tied to Higher Relapse Risk
August 1, 2025
Featured Experts: Geoffrey Joyce, PhD
Journal Article
Inside The Meteoric Rise Of Medicare Advantage
July 30, 2025
Featured Experts: Steven M. Lieberman, MPhil, MA
Evidence Base
A Value-Based Price for Anti-Obesity Medications
July 17, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
Journal Article
Proposal for a Value-Based Agreement to Reimburse Anti-Obesity Medicines in Traditional Medicare
July 11, 2025
Featured Experts: Alison Sexton Ward, PhD, Erin Trish, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
News
Most Medicare Beneficiaries May Pay More for Drugs Under the IRA
June 19, 2025
Featured Experts: Erin Trish, PhD
White Paper
Shifting Cost-Sharing Burden to Beneficiaries in Medicare Part D
June 19, 2025
Featured Experts: Erin Trish, PhD
Testimony
Testimony on IRA Implementation’s Threat to Medicine
May 20, 2025
Featured Experts: Erin Trish, PhD
Testimony
Testimony on Competition Issues in the Prescription Drug Supply Chain
May 13, 2025
Featured Experts: Neeraj Sood, PhD
News
Pharmacies Excluded from Preferred Networks Face Much Higher Risk of Closure
May 5, 2025
Featured Experts: Dima M. Qato, PharmD, MPH, PhD
Journal Article
Medicare Part D Preferred Pharmacy Networks And The Risk For Pharmacy Closure, 2014–23
May 5, 2025
Featured Experts: Genevieve P. Kanter, PhD, Dima M. Qato, PharmD, MPH, PhD
Perspective
A Missed Chance to Make America Healthier and Richer
April 7, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD